U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 1355

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:20101020-34485543
GRCh38:
Chr11:20079474-34463996
ABTB2, ANO3, ANO3-AS1, ANO5, ARL14EP, ARL14EP-DT, BBOX1, BBOX1-AS1, BDNF, BDNF-AS, C11orf91, CAPRIN1, CAT, CCDC179, CCDC34, CCDC73, CD59, CSTF3, CSTF3-DT, DBX1, DCDC1, DEPDC7, DNAJC24, EIF3M, ELP4, FANCF, FBXO3, FBXO3-DT, FIBIN, FSHB, GAS2, HIPK3, HTATIP2, IMMP1L, KCNA4, KIAA1549L, KIF18A, LGR4, LGR4-AS1, LIN7C, LINC00294, LINC00678, LINC01495, LINC01616, LINC02546, LINC02686, LINC02699, LINC02718, LINC02721, LINC02722, LINC02726, LINC02742, LINC02755, LINC02758, LINC02859, LINC03031, LMO2, LOC101928385, LOC105980003, LOC105980005, LOC105980073, LOC106007485, LOC106007493, LOC106014249, LOC106707172, LOC106707173, LOC107982234, LOC108178983, LOC108178984, LOC110120941, LOC110121388, LOC110121452, LOC111365162, LOC112067717, LOC112067718, LOC113939921, LOC116216130, LOC116216131, LOC116216132, LOC116216133, LOC121832789, LOC124421507, LOC124421508, LOC124421509, LOC124421510, LOC124421511, LOC124421512, LOC124421513, LOC124421514, LOC124421515, LOC124421516, LOC124421517, LOC124433243, LOC126861159, LOC126861160, LOC126861161, LOC126861162, LOC126861163, LOC126861164, LOC126861165, LOC126861166, LOC126861167, LOC126861168, LOC126861169, LOC126861170, LOC126861171, LOC126861172, LOC126861173, LOC126861174, LOC126861175, LOC126861176, LOC126861177, LOC126861178, LOC126861179, LOC126861180, LUZP2, METTL15, MIR610, MIR8054, MIR8068, MIR8087, MPPED2, MPPED2-AS1, MUC15, NAT10, NAV2, NELL1, PAUPAR, PAX6, PAX6-AS1, PAX6DRR, PAX6_HS2, PAX6_HS3, PAX6_HS8, PRMT3, PRRG4, QSER1, RCN1, SLC17A6, SLC5A12, SLC6A5, SNORA88, SVIP, TCP11L1, WT1, WT1-AS
See casesPathogenic
(Aug 30, 2010)
no assertion criteria provided
2.
GRCh37:
Chr11:22571661-38220709
GRCh38:
Chr11:22550115-38199159
ABTB2, ANO3, ANO3-AS1, APIP, ARL14EP, ARL14EP-DT, BBOX1, BBOX1-AS1, BDNF, BDNF-AS, C11orf91, CAPRIN1, CAT, CCDC179, CCDC34, CCDC73, CD44, CD44-AS1, CD44-DT, CD59, COMMD9, CSTF3, CSTF3-DT, DCDC1, DEPDC7, DNAJC24, EHF, EIF3M, ELF5, ELP4, FANCF, FBXO3, FBXO3-DT, FIBIN, FJX1, FSHB, GAS2, HIPK3, IFTAP, IMMP1L, KCNA4, KIAA1549L, KIF18A, LDLRAD3, LGR4, LGR4-AS1, LIN7C, LINC00294, LINC00678, LINC01616, LINC02546, LINC02686, LINC02699, LINC02707, LINC02718, LINC02721, LINC02722, LINC02726, LINC02742, LINC02755, LINC02758, LINC02760, LINC02859, LINC03031, LMO2, LOC101928385, LOC101928510, LOC105980003, LOC105980005, LOC105980073, LOC106007485, LOC106007493, LOC106014249, LOC106707172, LOC106707173, LOC107982234, LOC108178983, LOC108178984, LOC110120941, LOC110121388, LOC110121452, LOC112067717, LOC112067718, LOC112081392, LOC112081393, LOC113939921, LOC116216130, LOC116216131, LOC116216132, LOC116216133, LOC116216134, LOC121392907, LOC121392908, LOC121832789, LOC121832790, LOC124421508, LOC124421509, LOC124421510, LOC124421511, LOC124421512, LOC124421513, LOC124421514, LOC124421515, LOC124421516, LOC124421517, LOC124433243, LOC124433244, LOC124433245, LOC124433246, LOC124433247, LOC126861162, LOC126861163, LOC126861164, LOC126861165, LOC126861166, LOC126861167, LOC126861168, LOC126861169, LOC126861170, LOC126861171, LOC126861172, LOC126861173, LOC126861174, LOC126861175, LOC126861176, LOC126861177, LOC126861178, LOC126861179, LOC126861180, LOC126861181, LOC126861182, LOC126861183, LOC126861184, LOC126861185, LOC126861186, LOC126861187, LOC126861188, LOC126861189, LOC126861190, LOC126861191, LOC126861192, LOC126861193, LUZP2, METTL15, MIR1343, MIR3973, MIR610, MIR8054, MIR8068, MIR8087, MPPED2, MPPED2-AS1, MUC15, NAT10, PAMR1, PAUPAR, PAX6, PAX6-AS1, PAX6DRR, PAX6_HS2, PAX6_HS3, PAX6_HS8, PDHX, PRR5L, PRRG4, QSER1, RAG1, RAG2, RCN1, SLC1A2, SLC5A12, SNORA88, SNORD164, SVIP, TCP11L1, TRAF6, TRIM44, WT1, WT1-AS
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
3.
GRCh37:
Chr11:26390509-35274523
GRCh38:
Chr11:26368962-35252976
See casesPathogenic
(Nov 30, 2010)
no assertion criteria provided
4.
GRCh37:
Chr11:32409365
GRCh38:
Chr11:32387819
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Benign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
5.
GRCh37:
Chr11:32409379
GRCh38:
Chr11:32387833
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr11:32409395
GRCh38:
Chr11:32387849
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Benign/Likely benign
(Jan 12, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr11:32409437
GRCh38:
Chr11:32387891
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr11:32409472
GRCh38:
Chr11:32387926
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Benign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr11:32409506
GRCh38:
Chr11:32387960
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Benign/Likely benign
(Jan 12, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr11:32409538
GRCh38:
Chr11:32387992
WT1Wilms tumor 1, Meacham syndrome, Nephrotic syndrome, type 4
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr11:32409546
GRCh38:
Chr11:32388000
WT111p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
Meacham syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
12.
GRCh37:
Chr11:32409549-32409550
GRCh38:
Chr11:32388003-32388004
WT1Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome,
Meacham syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
13.
GRCh37:
Chr11:32409549-32409550
GRCh38:
Chr11:32388003-32388004
WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
14.
GRCh37:
Chr11:32409549-32409550
GRCh38:
Chr11:32388003-32388004
WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
15.
GRCh37:
Chr11:32409550-32409555
GRCh38:
Chr11:32388004-32388009
WT1Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome,
Meacham syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
16.
GRCh37:
Chr11:32409550-32409553
GRCh38:
Chr11:32388004-32388007
WT1Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
11p partial monosomy syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
17.
GRCh37:
Chr11:32409555
GRCh38:
Chr11:32388009
WT1Nephrotic syndrome, type 4, Nephroblastoma, Meacham syndrome
Benign
(Jun 14, 2016)
criteria provided, single submitter
18.
GRCh37:
Chr11:32409625-32409626
GRCh38:
Chr11:32388079-32388080
WT1Nephrotic syndrome, type 4, Meacham syndrome, Nephroblastoma
Benign
(Jun 14, 2016)
criteria provided, single submitter
19.
GRCh37:
Chr11:32409701
GRCh38:
Chr11:32388155
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Benign/Likely benign
(Jan 12, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr11:32409707
GRCh38:
Chr11:32388161
WT1Nephroblastoma, Nephrotic syndrome, type 4, 11p partial monosomy syndrome,
Meacham syndrome
Likely benign
(Jun 14, 2016)
criteria provided, single submitter
21.
GRCh37:
Chr11:32409740
GRCh38:
Chr11:32388194
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Benign/Likely benign
(Jan 12, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr11:32409740
GRCh38:
Chr11:32388194
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Benign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr11:32409763
GRCh38:
Chr11:32388217
WT111p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
Meacham syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
24.
GRCh37:
Chr11:32409769
GRCh38:
Chr11:32388223
WT1Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
Benign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr11:32409784
GRCh38:
Chr11:32388238
WT1Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
Benign
(Jan 13, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr11:32409819
GRCh38:
Chr11:32388273
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr11:32409836
GRCh38:
Chr11:32388290
WT111p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
Meacham syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
28.
GRCh37:
Chr11:32409863
GRCh38:
Chr11:32388317
WT111p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
Meacham syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
29.
GRCh37:
Chr11:32409897
GRCh38:
Chr11:32388351
WT1Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
11p partial monosomy syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
30.
GRCh37:
Chr11:32409919
GRCh38:
Chr11:32388373
WT1Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
11p partial monosomy syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
31.
GRCh37:
Chr11:32409938
GRCh38:
Chr11:32388392
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr11:32409975
GRCh38:
Chr11:32388429
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr11:32409990
GRCh38:
Chr11:32388444
WT1Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr11:32409993
GRCh38:
Chr11:32388447
WT1Nephrotic syndrome, type 4, Meacham syndrome, Wilms tumor 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr11:32410002
GRCh38:
Chr11:32388456
WT1Nephrotic syndrome, type 4, Wilms tumor 1, Meacham syndrome
Benign
(Jan 13, 2018)
criteria provided, single submitter
36.
GRCh37:
Chr11:32410030
GRCh38:
Chr11:32388484
WT1Meacham syndrome, Nephrotic syndrome, type 4, Nephroblastoma,
11p partial monosomy syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
37.
GRCh37:
Chr11:32410062
GRCh38:
Chr11:32388516
WT1Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
11p partial monosomy syndrome
Likely benign
(Jun 14, 2016)
criteria provided, single submitter
38.
GRCh37:
Chr11:32410070
GRCh38:
Chr11:32388524
WT1Wilms tumor 1, Nephrotic syndrome, type 4, Meacham syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr11:32410091
GRCh38:
Chr11:32388545
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr11:32410144
GRCh38:
Chr11:32388598
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr11:32410211
GRCh38:
Chr11:32388665
WT1Meacham syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
11p partial monosomy syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
42.
GRCh37:
Chr11:32410238
GRCh38:
Chr11:32388692
WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
43.
GRCh37:
Chr11:32410250
GRCh38:
Chr11:32388704
WT111p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
Meacham syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
44.
GRCh37:
Chr11:32410259
GRCh38:
Chr11:32388713
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Benign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr11:32410335
GRCh38:
Chr11:32388789
WT111p partial monosomy syndrome, Nephroblastoma, Nephrotic syndrome, type 4,
Meacham syndrome
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
46.
GRCh37:
Chr11:32410337
GRCh38:
Chr11:32388791
WT1not provided, Meacham syndrome, Nephrotic syndrome, type 4,
Frasier syndrome, Drash syndrome, Wilms tumor 1
Benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr11:32410365
GRCh38:
Chr11:32388819
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr11:32410380
GRCh38:
Chr11:32388834
WT1not provided, Meacham syndrome, Wilms tumor 1,
Nephrotic syndrome, type 4, Frasier syndrome, Drash syndrome
Benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr11:32410445
GRCh38:
Chr11:32388899
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr11:32410466
GRCh38:
Chr11:32388920
WT111p partial monosomy syndrome, Meacham syndrome, Nephroblastoma,
Nephrotic syndrome, type 4
Likely benign
(Jun 14, 2016)
criteria provided, single submitter
51.
GRCh37:
Chr11:32410494
GRCh38:
Chr11:32388948
WT1Meacham syndrome, Nephrotic syndrome, type 4, Wilms tumor 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr11:32410504
GRCh38:
Chr11:32388958
WT1Wilms tumor 1, Meacham syndrome, Nephrotic syndrome, type 4
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr11:32410516
GRCh38:
Chr11:32388970
WT1not provided, Wilms tumor 1, Meacham syndrome,
Frasier syndrome, Nephrotic syndrome, type 4, Drash syndrome
Benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr11:32410588
GRCh38:
Chr11:32389042
WT1not provided, Wilms tumor 1, Meacham syndrome,
Drash syndrome, Nephrotic syndrome, type 4, Frasier syndrome
Benign/Likely benign
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr11:32410592
GRCh38:
Chr11:32389046
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
56.
GRCh37:
Chr11:32410594-32456901
GRCh38:
Chr11:32389048-32435355
LOC106707172, LOC107982234, WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Pathogenic
(Sep 16, 2021)
criteria provided, single submitter
57.
GRCh37:
Chr11:32410594-32421600
GRCh38:
Chr11:32389048-32400054
WT1Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome
Uncertain significance
(Dec 23, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr11:32410599
GRCh38:
Chr11:32389053
WT1Meacham syndrome, Wilms tumor 1, Nephrotic syndrome, type 4
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr11:32410604
GRCh38:
Chr11:32389058
WT1Frasier syndrome, Drash syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr11:32410604-32456891
GRCh38:
Chr11:32389058-32435345
LOC106707172, LOC107982234, WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Pathogenic
(Sep 9, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr11:32410605
GRCh38:
Chr11:32389059
WT1Kidney disorder, Wilms tumor 1, Meacham syndrome,
Nephrotic syndrome, type 4, Drash syndrome, Frasier syndrome,
Wilms tumor 1, 11p partial monosomy syndrome, not provided
Conflicting interpretations of pathogenicity
(Sep 14, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr11:32410610
GRCh38:
Chr11:32389064
WT1Drash syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Frasier syndrome
Likely benign
(Nov 15, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr11:32410610
GRCh38:
Chr11:32389064
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Likely benign
(Oct 5, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr11:32410611
GRCh38:
Chr11:32389065
WT1A125V, A287V, A301V, A518V, A521V, A501V, A463V, A490V, A504V, A474V, A477V, A499V, A516V, A267V, A473VDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Aniridia 1, Nephrotic syndrome, type 4,
Drash syndrome, Frasier syndrome, Wilms tumor 1,
Meacham syndrome, Mesothelioma, malignant11p partial monosomy syndrome,
not provided, ...see more
Uncertain significance
(Dec 13, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr11:32410612
GRCh38:
Chr11:32389066
WT1A125P, A301P, A287P, A501P, A518P, A521P, A473P, A490P, A504P, A516P, A267P, A474P, A499P, A463P, A477PDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Jan 26, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr11:32410614
GRCh38:
Chr11:32389068
WT1L517P, L300P, L520P, L124P, L286P, L500P, L266P, L473P, L515P, L472P, L503P, L489P, L462P, L476P, L498PDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Inborn genetic diseases, Meacham syndrome,
Mesothelioma, malignant, Aniridia 1, Drash syndrome,
Nephrotic syndrome, type 4, Frasier syndromeWilms tumor 1,
11p partial monosomy syndrome, ...see more
Uncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr11:32410616
GRCh38:
Chr11:32389070
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Likely benign
(Mar 30, 2019)
criteria provided, single submitter
68.
GRCh37:
Chr11:32410618
GRCh38:
Chr11:32389072
WT1Q285*, Q499*, Q123*, Q519*, Q299*, Q516*, Q265*, Q471*, Q497*, Q514*, Q461*, Q472*, Q502*, Q475*, Q488*Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr11:32410619
GRCh38:
Chr11:32389073
WT1Wilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome,
Drash syndrome
Likely benign
(Feb 27, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr11:32410628
GRCh38:
Chr11:32389082
WT1M281I, M515I, M295I, M495I, M512I, M119I, M498I, M493I, M510I, M261I, M457I, M467I, M484I, M468I, M471IDrash syndrome, Wilms tumor 1, Frasier syndrome,
11p partial monosomy syndrome
Uncertain significance
(Sep 2, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr11:32410632
GRCh38:
Chr11:32389086
WT1N294T, N456T, N467T, N509T, N511T, N466T, N470T, N492T, N497T, N118T, N494T, N260T, N280T, N483T, N514TWilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome,
Drash syndrome
Uncertain significance
(Feb 28, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr11:32410632
GRCh38:
Chr11:32389086
WT1N294S, N514S, N280S, N494S, N118S, N511S, N467S, N470S, N466S, N483S, N497S, N260S, N456S, N492SDrash syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Frasier syndrome, Drash syndrome, Wilms tumor 1
Uncertain significance
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr11:32410632
GRCh38:
Chr11:32389086
WT1N294I, N514I, N118I, N511I, N280I, N494I, N483I, N467I, N260I, N466I, N492I, N497I, N456I, N470IDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Aug 26, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr11:32410635
GRCh38:
Chr11:32389089
WT1R293T, R513T, R117T, R279T, R510T, R493T, R496T, R259T, R455T, R469T, R482T, R465T, R466T, R491TDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr11:32410639
GRCh38:
Chr11:32389093
WT1Q116*, Q278*, Q292*, Q492*, Q509*, Q512*, Q464*, Q454*, Q465*, Q490*, Q495*, Q507*, Q258*, Q468*, Q481*Nephrotic syndrome, type 4Pathogeniccriteria provided, single submitter
76.
GRCh37:
Chr11:32410644
GRCh38:
Chr11:32389098
WT1M114K, M276K, M290K, M490K, M507K, M510K, M463K, M466K, M479K, M493K, M256K, M452K, M462K, M505K, M488KWilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome,
Drash syndrome
Uncertain significance
(Oct 24, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr11:32410645
GRCh38:
Chr11:32389099
WT1M510V, M290V, M276V, M114V, M507V, M490V, M452V, M462V, M463V, M488V, M493V, M466V, M256V, M479VDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Oct 20, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr11:32410647
GRCh38:
Chr11:32389101
WT1N275I, N289I, N506I, N489I, N509I, N113I, N451I, N461I, N504I, N255I, N465I, N492I, N462I, N478I, N487IFrasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome
Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr11:32410649
GRCh38:
Chr11:32389103
WT1H288Q, H508Q, H488Q, H505Q, H112Q, H274Q, H450Q, H254Q, H460Q, H464Q, H477Q, H486Q, H491Q, H461QDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Jan 6, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr11:32410656
GRCh38:
Chr11:32389110
WT1R272L, R110L, R486L, R503L, R286L, R506L, R252L, R458L, R475L, R484L, R489L, R501L, R448L, R459L, R462LFrasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome
Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr11:32410657
GRCh38:
Chr11:32389111
WT1R272C, R475C, R503C, R110C, R462C, R252C, R448C, R486C, R489C, R286C, R458C, R459C, R484C, R501C, R506CWilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome,
Drash syndrome
Uncertain significance
(Jul 19, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr11:32410658
GRCh38:
Chr11:32389112
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Likely benign
(Aug 26, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr11:32410660
GRCh38:
Chr11:32389114
WT1V109L, V271L, V285L, V502L, V505L, V485L, V457L, V458L, V461L, V500L, V474L, V251L, V483L, V488L, V447LDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr11:32410663
GRCh38:
Chr11:32389117
WT1L456V, L457V, L487V, L270V, L473V, L499V, L504V, L108V, L250V, L446V, L482V, L501V, L284V, L460V, L484VWilms tumor 1, Drash syndrome, 11p partial monosomy syndrome,
Frasier syndrome
Uncertain significance
(Feb 18, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr11:32410673
GRCh38:
Chr11:32389127
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Likely benign
(Jul 23, 2020)
criteria provided, single submitter
86.
GRCh37:
Chr11:32410674
GRCh38:
Chr11:32389128
WT1R480Q, R497Q, R280Q, R104Q, R266Q, R500Q, R442Q, R483Q, R495Q, R452Q, R453Q, R456Q, R469Q, R246Q, R478QDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Pathogenic
(Jun 14, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr11:32410675
GRCh38:
Chr11:32389129
WT1R104W, R246W, R266W, R280W, R442W, R452W, R453W, R456W, R469W, R478W, R480W, R483W, R495W, R497W, R500WWT1-related disorderLikely pathogenic
(Feb 7, 2023)
criteria provided, single submitter
88.
GRCh37:
Chr11:32410677
GRCh38:
Chr11:32389131
WT1A103G, A279G, A479G, A496G, A499G, A265G, A452G, A482G, A451G, A477G, A441G, A494G, A245G, A455G, A468GFrasier syndrome, Wilms tumor 1, 11p partial monosomy syndrome,
Drash syndrome
Uncertain significance
(Nov 5, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr11:32410686
GRCh38:
Chr11:32389140
WT1K476R, K496R, K262R, K493R, K100R, K276R, K438R, K452R, K448R, K449R, K242R, K479R, K465R, K474R, K491RAniridia 1, Meacham syndrome, Mesothelioma, malignant,
Wilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Nephrotic syndrome, type 4, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Drash syndromeFrasier syndrome,
...see more
Uncertain significance
(Oct 22, 2021)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr11:32410688
GRCh38:
Chr11:32389142
WT1Q261H, Q275H, Q437H, Q464H, Q473H, Q475H, Q490H, Q495H, Q241H, Q451H, Q99H, Q447H, Q492H, Q448H, Q478HWilms tumor 1, 11p partial monosomy syndrome, Frasier syndrome,
Drash syndrome
Uncertain significance
(Jan 27, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr11:32410694
GRCh38:
Chr11:32389148
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Likely benign
(Mar 9, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr11:32410695
GRCh38:
Chr11:32389149
WT1S273N, S493N, S259N, S490N, S97N, S473N, S239N, S446N, S449N, S435N, S462N, S471N, S445N, S476NWilms tumor 1, Frasier syndrome, Wilms tumor 1,
Drash syndrome, 11p partial monosomy syndrome, Frasier syndrome
Uncertain significance
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr11:32410696
GRCh38:
Chr11:32389150
WT1S493G, S97G, S473G, S490G, S259G, S273G, S449G, S471G, S476G, S488G, S239G, S445G, S446G, S462G, S435GDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome, Hereditary cancer-predisposing syndrome
Uncertain significance
(Aug 6, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr11:32410696
GRCh38:
Chr11:32389150
WT1S273R, S473R, S493R, S259R, S490R, S97R, S471R, S476R, S239R, S435R, S446R, S445R, S462R, S449R, S488RWilms tumor 1, 11p partial monosomy syndrome, Drash syndrome,
Frasier syndrome
Uncertain significance
(Aug 26, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr11:32410697
GRCh38:
Chr11:32389151
WT1Drash syndrome, Wilms tumor 1, Frasier syndrome,
11p partial monosomy syndrome
Likely benign
(Oct 1, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr11:32410699
GRCh38:
Chr11:32389153
WT1P272S, P492S, P489S, P258S, P472S, P96S, P444S, P434S, P448S, P475S, P470S, P238S, P445S, P461SDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr11:32410704
GRCh38:
Chr11:32389158
WT1R270Q, R490Q, R256Q, R470Q, R487Q, R94Q, R446Q, R459Q, R236Q, R442Q, R443Q, R468Q, R473Q, R432QFrasier syndrome, Drash syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Oct 5, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr11:32410705
GRCh38:
Chr11:32389159
WT1R270W, R490W, R487W, R94W, R256W, R470W, R459W, R432W, R443W, R442W, R446W, R236W, R468W, R473WDrash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Uncertain significance
(Aug 8, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr11:32410706
GRCh38:
Chr11:32389160
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Likely benign
(Sep 23, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr11:32410709
GRCh38:
Chr11:32389163
WT1Drash syndrome, Frasier syndrome, Wilms tumor 1,
11p partial monosomy syndrome
Likely benign
(Jun 4, 2018)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination